Phosphatidylserine externalization in sickle red blood cells: Associations with cell age, density, and hemoglobin F

Blood

Volumn 102, Issue 1, 2003, Pages 365-370

  Yasin, Zahida ^a   Witting, Scott ^b   Palascak, Mary B ^b   Joiner, Clinton H ^b   Rucknagel, Donald L ^b   Franco, Robert S ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; HEMOGLOBIN F; PHOSPHATIDYLSERINE; TRANSFERRIN RECEPTOR;

ARTICLE; CELL AGING; CELL DENSITY; CELL FRACTIONATION; CELL ISOLATION; CELL LABELING; CELL LEVEL; CELL MATURATION; CELL MEMBRANE TRANSPORT; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEHYDRATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDRATION; PRIORITY JOURNAL; SICKLE CELL; SICKLE CELL ANEMIA; SICKLE CELL TRAIT;

EID: 0037902091     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3416     Document Type: Article

References (25)

1. Lubin B, Chiu D, Bastacky J, Roelofsen B, Van Deenen LL. Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest. 1981;67:1643-1649.
2. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
3. Kuypers FA, Lewis RS, Hua M, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood. 1996;87:1179-1187.
4. de Jong K, Larkin SK, Styles LA, Bookchin RM, Kuypers FA. Characterization of the phosphatidylserine-exposing subpopulation of sickle cells. Blood. 2001;98:860-867.
5. Blumenfeld N, Zachowski A, Galacteros F, Beuzard Y, Devaux PF. Transmembrane mobility of phospholipids in sickle erythrocytes: effect of deoxygenation on diffusion and asymmetry. Blood. 1991;77:849-854.
6. Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells: relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem. 1994;269:2399-2404.
7. Fadok VA, Warner ML, Bratton DL, Henson PM. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (avb3). J Immunol. 1998;161:6250-6257.
8. Krahling S, Callahan MK, Williamson P, Schlegel RA. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 1999;6:183-189.
9. Franco RS, Yasin Z, Lohmann JM, et al. The survival characteristics of dense sickle cells. Blood. 2000;96:3610-3617.
10. de Jong K, Emerson RK, Butler J, et al. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood. 2001;98:1577-1584.
11. Chiu D, Lubin B, Roelofsen B, van Deenen LLM. Sickled erythrocytes accelerate clotting in vitro: an effect of abnormal membrane lipid asymmetry. Blood. 1981;58:398-401.
12. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 2000;95:1293-1300.
13. Styles L, de Yong K, Vichinsky E, et al. Increased RBC phosphatidlyserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening [abstract]. Blood. 1997;90:604-605.
14. Dover GJ, Boyer SH. Fetal hemoglobin-containing cells have the same mean corpuscular hemoglobin as cells without fetal hemoglobin: a reciprocal relationship between γ- and β-globin gene expression in normal subjects and in those with high fetal hemoglobin production. Blood. 1987;69:1109-1113.
15. Dover GJ, Boyer SH, Charache S, Heintzelman MS. Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med. 1978;299:1428-1435.
16. Joiner CH. Cation transport and volume regulation in sickle red blood cells. Am J Physiol. 1993;264 (Cell Physiol 33):C251-C270.
17. Yasin Z, Witting S, Palascak MB, et al. Loss of sickle RBC phospholipid asymmetry is associated with increased fluorescence of the calcium-dependent fluorochrome Fluo-3 [abstract]. Blood. 1999;94:196.
18. Wilson JB, Headlee ME, Huisman TH. Anew high performance liquid chromatographic procedure for the separation and quantitation of various hemogobin variants in adults and newborn babies. J Lab Clin Med. 1983;102:174-186.
19. Franco RS, Lohmann J, Silberstein EB, et al. Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest. 1998;101:2730-2740.
20. 51Cr-labeled red cells. Transfusion. 1999;39:156-162.
21. Setty BN, Kulkarni S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 2000;96:1119-1124.
22. Bertles JF, Milner PFA. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia. J Clin Invest. 1968;47:1731-1741.
23. Pradhan D, Williamson P, Schleger RA. Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids. Mol Membr Biol. 1994;11:181-187.
24. Kean LS, Brown LE, Nichols JW, et al. Comparison of mechanisms of anemia in mice with sickle cell disease and β-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure. Exp Hematol. 2002;30:394-402.
25. Paszty C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997;278:876-878.